Company / CIK 0001326110
ImmunityBio, Inc.
- Ticker
- IBRX
- Size, estimated from filings
- Large cap ($10B – $200B)
- Insiders on file
- 7
- Members of Congress who traded it
- 1
- Federal contracts on record
- none matched
- Lobbying filings on record
- 4
- SEC filings
- EDGAR ↗
- Latest trade on record
- October 5, 2026
ImmunityBio, Inc. (IBRX) has 7 insiders on file who disclosed 29 transactions in the last 12 months (0 open-market buys, 7 sales, about $6.0M at reported prices), and 2 congressional trades in its stock are on record. No federal contract award that started in the last 180 days was found for a recipient with exactly this name, and 2 lobbying filings naming it as client report $60K in 2026.
ImmunityBio, Inc. in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
4 people account for the disclosed buying and selling in ImmunityBio, Inc. over the last 12 months; the most active is Selecky Christobel with $2.3M.
Lobbying spend by quarter
How much has ImmunityBio, Inc. reported spending on federal lobbying?
ImmunityBio, Inc. reported $120K in lobbying over the last eight quarters, from filings matched by exact company name.
Insiders
| Name | Role | Rows | Bought | Sold | Last filed |
|---|---|---|---|---|---|
| Simon Barry J. | Director | 2 | 0 | 2 | October 6, 2026 |
| Cohen Cheryl | Director | 6 | 0 | 2 | October 6, 2026 |
| MAXWELL LINDA | Director | 1 | 0 | 0 | July 23, 2026 |
| Selecky Christobel | Director | 17 | 0 | 3 | July 6, 2026 |
| BLASZYK MICHAEL D | Director | 1 | 0 | 0 | June 10, 2026 |
| Wendel Bruce | Director | 1 | 0 | 0 | June 10, 2026 |
| Clark Wesley | Director | 1 | 0 | 0 | June 10, 2026 |
Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.
Members of Congress who traded IBRX
From periodic transaction reports that name the company's stock. Amounts are the sums of the ranges as filed. Every row is on the IBRX page.
| Member | Seat | Trades | Bought | Sold | Range as filed | Latest |
|---|---|---|---|---|---|---|
| Lisa C. McClain | Representative (MI, District 9), Republican | 2 | 2 | 0 | $2,002–$30K | September 30, 2026 |
Insider transactions
| Filer | Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cohen Cheryl | IBRX | Option / conversion M | October 2, 2026 | October 6, 2026 | 4d | 55,979 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Cohen Cheryl | IBRX | Sell S | October 2, 2026 | October 6, 2026 | 4d | 81,056 | $11 | $851K | 10b5-1 plan | Form 4 ↗ | |
| Cohen Cheryl | IBRX | Option / conversion M | October 2, 2026 | October 6, 2026 | 4d | 55,979 | $3 | $167K | 10b5-1 plan | Form 4 ↗ | |
| Simon Barry J. | IBRX | Sell S | October 5, 2026 | October 6, 2026 | 1d | 25,000 | $11 | $269K | 10b5-1 plan | Form 4 ↗ | |
| Selecky Christobel | IBRX | Option / conversion M | July 1, 2026 | July 6, 2026 | 5d | 124,414 | — | — | late10b5-1 planderivative | Form 4 ↗ | |
| Selecky Christobel | IBRX | Option / conversion M | July 1, 2026 | July 6, 2026 | 5d | 35,064 | — | — | late10b5-1 planderivative | Form 4 ↗ | |
| Selecky Christobel | IBRX | Sell S | July 1, 2026 | July 6, 2026 | 5d | 159,478 | $9 | $1.4M | late10b5-1 plan | Form 4 ↗ | |
| Selecky Christobel | IBRX | Option / conversion M | July 1, 2026 | July 6, 2026 | 5d | 124,414 | $3 | $372K | late10b5-1 plan | Form 4 ↗ | |
| Selecky Christobel | IBRX | Option / conversion M | July 1, 2026 | July 6, 2026 | 5d | 35,064 | $3 | $104K | late10b5-1 plan | Form 4 ↗ | |
| Cohen Cheryl | IBRX | Option / conversion M | July 2, 2026 | July 6, 2026 | 4d | 55,979 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Cohen Cheryl | IBRX | Sell S | July 2, 2026 | July 6, 2026 | 4d | 131,210 | $10 | $1.2M | 10b5-1 plan | Form 4 ↗ | |
| Cohen Cheryl | IBRX | Option / conversion M | July 2, 2026 | July 6, 2026 | 4d | 55,979 | $3 | $167K | 10b5-1 plan | Form 4 ↗ | |
| Selecky Christobel | IBRX | Option / conversion M | June 30, 2026 | July 1, 2026 | 1d | 300 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Selecky Christobel | IBRX | Option / conversion M | June 30, 2026 | July 1, 2026 | 1d | 700 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Selecky Christobel | IBRX | Option / conversion M | June 29, 2026 | July 1, 2026 | 2d | 30,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Selecky Christobel | IBRX | Option / conversion M | June 29, 2026 | July 1, 2026 | 2d | 33,549 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Selecky Christobel | IBRX | Option / conversion M | June 29, 2026 | July 1, 2026 | 2d | 32,173 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Selecky Christobel | IBRX | Sell S | June 30, 2026 | July 1, 2026 | 1d | 1,000 | $9 | $9,000 | 10b5-1 plan | Form 4 ↗ | |
| Selecky Christobel | IBRX | Option / conversion M | June 30, 2026 | July 1, 2026 | 1d | 300 | $3 | $897 | 10b5-1 plan | Form 4 ↗ | |
| Selecky Christobel | IBRX | Option / conversion M | June 30, 2026 | July 1, 2026 | 1d | 700 | $3 | $2,086 | 10b5-1 plan | Form 4 ↗ | |
| Selecky Christobel | IBRX | Sell S | June 29, 2026 | July 1, 2026 | 2d | 95,722 | $9 | $862K | 10b5-1 plan | Form 4 ↗ | |
| Selecky Christobel | IBRX | Option / conversion M | June 29, 2026 | July 1, 2026 | 2d | 30,000 | $3 | $85K | 10b5-1 plan | Form 4 ↗ | |
| Selecky Christobel | IBRX | Option / conversion M | June 29, 2026 | July 1, 2026 | 2d | 33,549 | $3 | $100K | 10b5-1 plan | Form 4 ↗ | |
| Selecky Christobel | IBRX | Option / conversion M | June 29, 2026 | July 1, 2026 | 2d | 32,173 | $3 | $96K | 10b5-1 plan | Form 4 ↗ | |
| Simon Barry J. | IBRX | Sell S | June 24, 2026 | June 26, 2026 | 2d | 25,000 | $8 | $197K | 10b5-1 plan | Form 4 ↗ | |
| Clark Wesley | IBRX | Other A | June 9, 2026 | June 10, 2026 | 1d | 65,600 | — | — | derivative | Form 4 ↗ | |
| MAXWELL LINDA | IBRX | Other A | June 9, 2026 | June 10, 2026 | 1d | 65,600 | — | — | derivative | Form 4 ↗ | |
| Wendel Bruce | IBRX | Other A | June 9, 2026 | June 10, 2026 | 1d | 65,600 | — | — | derivative | Form 4 ↗ | |
| BLASZYK MICHAEL D | IBRX | Other A | June 9, 2026 | June 10, 2026 | 1d | 65,600 | — | — | derivative | Form 4 ↗ |
Federal contracts (USAspending, awards started in the last 180 days)
No contract award starting in the last 180 days was found for a recipient named exactly "ImmunityBio, Inc.". Subsidiaries and differently-spelled recipients are not matched — search contracts.
Lobbying (Senate LDA, as client)
| Period | Registrant | Primary issue | Amount | Source |
|---|---|---|---|---|
| 2026 Q2 | CONTINENTAL STRATEGY, LLC | — | — | LDA ↗ |
| 2026 Q1 | CONTINENTAL STRATEGY, LLC | — | $60,000 | LDA ↗ |
| 2025 Q4 | CONTINENTAL STRATEGY, LLC | Health Issues | $60,000 | LDA ↗ |
| 2025 Q4 | CONTINENTAL STRATEGY, LLC | Medical/Disease Research/Clinical Labs | — | LDA ↗ |
Related companies
Companies whose stock was traded by the same people who traded IBRX, by number of filers in common. It shows overlap in public filings and nothing else.
- UNITED THERAPEUTICS Corp UTHR 2 filers in common
- Dell Technologies Inc. DELL 1 filer in common
- Seagate Technology Holdings plc STX 1 filer in common
- Uber Technologies, Inc UBER 1 filer in common
- Datadog, Inc. DDOG 1 filer in common
- Arista Networks, Inc. ANET 1 filer in common
- Meta Platforms, Inc. META 1 filer in common
- Albertsons Companies, Inc. ACI 1 filer in common
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Lobbying disclosure reports Reports are due about 20 days after each quarter ends.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| House Clerk, periodic transaction reports | 1 | 2 | October 12, 2026 | October 12, 2026 | House Clerk search |
| SEC EDGAR, Form 4 | 10 | 29 | June 10, 2026 | October 6, 2026 | Form 4 list on EDGAR |
| Lobbying disclosure filings | 4 filings | — | — | — | LDA.gov search |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.
Not investment advice. Public records shown as filed; no recommendation is made or implied.